OCX: OncoCyte Corporation Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 21.18
Enterprise Value ($M) 16.87
Book Value ($M) 25.59
Book Value / Share 3.09
Price / Book 0.83
NCAV ($M) -38.60
NCAV / Share -4.67
Price / NCAV -0.55

Profitability (mra)
Return on Invested Capital (ROIC) -0.98
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.64

Liquidity (mrq)
Quick Ratio 1.49
Current Ratio 1.49

Balance Sheet (mrq) ($M)
Current Assets 10.70
Assets 74.89
Liabilities 49.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.50
Operating Income -22.86
Net Income -27.78
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -23.32
Cash from Investing -0.93
Cash from Financing 12.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
5 days ago 13D/A Broadwood Partners, L.p. 37.60 -91.11
02-14 13G/A Pura Vida Investments, Llc 8.45 -95.74
02-14 13G/A AWM Investment Company, Inc. 9.10 -89.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 4,650 45,843 10.14
2024-04-18 4,881 6,647 73.43
2024-04-17 8,292 35,980 23.05
2024-04-16 32,926 170,984 19.26
2024-04-15 29,004 110,351 26.28

(click for more detail)

Similar Companies
OCEA – Ocean Biomedical, Inc. OCGN – Ocugen, Inc.
OCUP – Ocuphire Pharma, Inc. OKYO – OKYO Pharma Limited
ONCO – Onconetix, Inc.


Financial data and stock pages provided by
Fintel.io